{"id":35593,"date":"2026-02-10T20:07:25","date_gmt":"2026-02-10T20:07:25","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/oncology-clinical-trials-market-mordor\/"},"modified":"2026-10-02T17:32:30","modified_gmt":"2026-10-02T08:32:30","slug":"oncology-clinical-trials-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/oncology-clinical-trials-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026 &#8211; 2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/oncology-clinical-trials-market-1750141503963-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/oncology-clinical-trials-market-size-image-1767810329604.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc804 \uc138\uacc4 \uc554 \ubc1c\uc0dd\ub960 \ubc0f \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc81c\uc57d \ubc0f \ubc14\uc774\uc624\ud14d \uc885\uc591\ud559 R&amp;D \uc9c0\ucd9c \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc2e0\uc18d \uc2ec\uc0ac \uacbd\ub85c (\ud601\uc2e0 \uce58\ub8cc\uc81c, \ud504\ub77c\uc784 \ub4f1)<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc815\ubc00 \uc758\ud559 \ubc0f \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \uce58\ub8cc \ubaa8\uba58\ud140<\/li>\n<li class=\"toc-level-3\">4.2.5 \uc2e0\ud765 \uc2dc\uc7a5 2\ucc28 \ubcd1\uc6d0\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \uc0ac\uc774\ud2b8 \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.6 \ud558\uc774\ube0c\ub9ac\ub4dc \uc99d\uac70 \ud504\ub85c\ud1a0\ucf5c\uc744 \ud615\uc131\ud558\ub294 \uc2e4\uc81c \ub370\uc774\ud130 \ud1b5\ud569<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc5c4\uaca9\ud558\uace0 \ubcf5\uc7a1\ud55c \uc790\uaca9 \uae30\uc900\uc774 \ubaa8\uc9d1\uc744 \ub2a6\ucda4<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc99d\uac00\ud558\ub294 \uc784\uc0c1 \uc2dc\ud5d8 \ube44\uc6a9 \ubc0f \uc6b4\uc601 \ubd80\ub2f4<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc911\ubcf5\ub418\ub294 \uacbd\uc7c1 \uc5f0\uad6c\ub85c \uc778\ud55c \ud658\uc790 \ud480 \ud3ec\ud654<\/li>\n<li class=\"toc-level-3\">4.3.4 \uad6d\uacbd \uac04 \ub370\uc774\ud130 \uac1c\uc778 \uc815\ubcf4 \ubcf4\ud638\ubc95\uc774 \ub2e4\uc9c0\uc5ed \uc784\uc0c1 \uc2dc\ud5d8\uc744 \ubcf5\uc7a1\ud558\uac8c \ud568<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uad6c\ub9e4\uc790\/?\uc2a4\ud3f0\uc11c\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.2 CRO\/?\uc0ac\uc774\ud2b8 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611 (\uc2e4\uc81c \uc99d\uac70, \uc778\uc2e4\ub9ac\ucf54)<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \ub2e8\uacc4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 1\uc0c1<\/li>\n<li class=\"toc-level-3\">5.1.2 2\uc0c1<\/li>\n<li class=\"toc-level-3\">5.1.3 3\uc0c1<\/li>\n<li class=\"toc-level-3\">5.1.4 4\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc124\uacc4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uce58\ub8cc \/ \uc911\uc7ac \uc5f0\uad6c<\/li>\n<li class=\"toc-level-3\">5.2.2 \uad00\ucc30 \uc5f0\uad6c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc554 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ud3d0\uc554<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\ubc29\uc554<\/li>\n<li class=\"toc-level-3\">5.3.3 \ub300\uc7a5\uc554<\/li>\n<li class=\"toc-level-3\">5.3.4 \ubc31\ud608\ubcd1<\/li>\n<li class=\"toc-level-3\">5.3.5 \uc804\ub9bd\uc120\uc554<\/li>\n<li class=\"toc-level-3\">5.3.6 \uae30\ud0c0 \uc554<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uce58\ub8cc \uc591\uc2dd\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uba74\uc5ed \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.4.2 \ud45c\uc801 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.4.3 \ud654\ud559 \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc138\ud3ec &amp; \uc720\uc804\uc790 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.4.5 \uae30\ud0c0 \uce58\ub8cc \uc591\uc2dd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd\n<ul>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\n<ul>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74\n<ul>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \uc0ac\uc5c5 \ubd80\ubb38, \uc7ac\ubb34, \uc778\ub825, \uc8fc\uc694 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704, \uc2dc\uc7a5 \uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uc2e0 \uac1c\ubc1c \ubd84\uc11d \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 IQVIA<\/li>\n<li class=\"toc-level-3\">6.3.2 Parexel International<\/li>\n<li class=\"toc-level-3\">6.3.3 ICON plc<\/li>\n<li class=\"toc-level-3\">6.3.4 Syneos Health<\/li>\n<li class=\"toc-level-3\">6.3.5 Labcorp Drug Development<\/li>\n<li class=\"toc-level-3\">6.3.6 Thermo Fisher Scientific (PPD)<\/li>\n<li class=\"toc-level-3\">6.3.7 Medpace Holdings<\/li>\n<li class=\"toc-level-3\">6.3.8 Charles River Laboratories<\/li>\n<li class=\"toc-level-3\">6.3.9 Wuxi Clinical CRO<\/li>\n<li class=\"toc-level-3\">6.3.10 AstraZeneca PLC<\/li>\n<li class=\"toc-level-3\">6.3.11 Johnson &amp; Johnson<\/li>\n<li class=\"toc-level-3\">6.3.12 F. Hoffmann-La Roche Ltd<\/li>\n<li class=\"toc-level-3\">6.3.13 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.14 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.15 Bristol Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.3.16 Merck &amp; Co., Inc.<\/li>\n<li class=\"toc-level-3\">6.3.17 AbbVie Inc.<\/li>\n<li class=\"toc-level-3\">6.3.18 Eli Lilly and Company<\/li>\n<li class=\"toc-level-3\">6.3.19 Takeda Pharmaceutical<\/li>\n<li class=\"toc-level-3\">6.3.20 BeiGene Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.21 Clovis Oncology<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc218\uce58<\/p>\n<p>\ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 \uc804 \uc138\uacc4\uc801\uc778 \uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00, \uc815\ubc00 \uc758\ud559\uc758 \ubc1c\uc804, \uadf8\ub9ac\uace0 \ud601\uc2e0 \uce58\ub8cc\ubc95\uc5d0 \ub300\ud55c \uaddc\uc81c \ub2f9\uad6d\uc758 \uc2e0\uc18d \uc2b9\uc778 \uc758\uc9c0\uc5d0 \ud798\uc785\uc5b4 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. Mordor Intelligence\uc758 \ubd84\uc11d\uc5d0 \ub530\ub974\uba74, \ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 2025\ub144 139.1\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 146.3\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud588\uc73c\uba70, 2031\ub144\uc5d0\ub294 187.9\uc5b5 \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud558\uc5ec \uc608\uce21 \uae30\uac04(2026-2031) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 5.14%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc870\uc0ac \uae30\uac04\uc740 2020\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc774\uba70, \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc744 \ucc28\uc9c0\ud558\uace0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc774\uba70, \uc8fc\uc694 \uacc4\uc57d \uc5f0\uad6c \uae30\uad00(CRO)\ub4e4\uc774 \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825<\/p>\n<p>*   \uc804 \uc138\uacc4 \uc554 \ubc1c\ubcd1\ub960 \ubc0f \uc720\ubcd1\ub960 \uc99d\uac00: 2050\ub144\uae4c\uc9c0 \uc5f0\uac04 \uc554 \ubc1c\ubcd1 \uac74\uc218\uac00 3,500\ub9cc \uac74\uc744 \ub118\uc5b4\uc124 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc774\ub294 \ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc5d0 \uc9c0\uc18d\uc801\uc778 \uc218\uc694\ub97c \ucc3d\ucd9c\ud558\ub294 \uac00\uc7a5 \ud070 \uc694\uc778\uc785\ub2c8\ub2e4. \uc120\uc9c4\uad6d\uc758 \uace0\ub839\ud654\uc640 \uc2e0\ud765 \uc2dc\uc7a5\uc758 \uc0dd\ud65c \uc2b5\uad00 \ubcc0\ud654\uac00 \uc5ed\ud559\uc744 \ubcc0\ud654\uc2dc\ud0a4\uace0 \uc788\uc73c\uba70, \ubc14\uc774\uc624\ub9c8\ucee4\ub85c \uc815\uc758\ub41c \ud658\uc790 \ud558\uc704 \uadf8\ub8f9\uc740 \ud45c\uc801\ud654\ub41c \ubaa8\uc9d1 \uc804\ub7b5\uc744 \ud544\uc694\ub85c \ud569\ub2c8\ub2e4. \ud2b9\ud788 \uc911\uad6d\uc758 \ub300\uaddc\ubaa8 \ubbf8\uce58\ub8cc \ud658\uc790\uad70\uc740 \uad6d\ub0b4\uc678 \uc2a4\ud3f0\uc11c\ub4e4\uc758 \uad00\uc2ec\uc744 \ub04c\uace0 \uc788\uc73c\uba70, \uc9c0\uc5ed \uc554 \ub4f1\ub85d \ub370\uc774\ud130\ub294 \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \ud658\uc790 \ub4f1\ub85d\uc5d0 \ud544\uc218\uc801\uc785\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uae30\uc5c5\uc758 \ud56d\uc554 R&#038;D \ud22c\uc790 \ud655\ub300: \uc8fc\uc694 \uc81c\uc57d\uc0ac\ub4e4\uc740 2024\ub144 \uac1c\ubc1c \uc608\uc0b0\uc758 40~50%\ub97c \ud56d\uc554 \ud504\ub85c\uadf8\ub7a8\uc5d0 \ud22c\uc785\ud588\uc73c\uba70, \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74\ub294 2030\ub144\uae4c\uc9c0 800\uc5b5 \ub2ec\ub7ec \ub9e4\ucd9c \ubaa9\ud45c\ub97c \ud1b5\ud574 \ud56d\uc554 \ubd84\uc57c \uc9d1\uc911\uc744 \uac15\uc870\ud588\uc2b5\ub2c8\ub2e4. \ubca4\ucc98 \uce90\ud53c\ud0c8\uc758 \ud56d\uc554 \uc2a4\ud0c0\ud2b8\uc5c5 \ud22c\uc790\ub294 2024\ub144\uc5d0 \uae30\ub85d\uc744 \uacbd\uc2e0\ud588\uc73c\uba70, \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC) \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c\uc640 \uac19\uc740 \ud50c\ub7ab\ud3fc \uae30\uc220\uc740 \ub192\uc740 \ucd08\uae30 \uc790\ubcf8\uc744 \uc694\uad6c\ud558\uc9c0\ub9cc \ubc18\ubcf5 \uac00\ub2a5\ud55c \uc801\uc751\uc99d\uc744 \uc57d\uc18d\ud558\uba70 \uc2a4\ud3f0\uc11c\ub4e4\uc774 \uc804\ubb38 \ubc14\uc774\uc624\ud14d\uacfc\uc758 \ud611\ub825\uc744 \uc2ec\ud654\ud558\ub3c4\ub85d \uc720\ub3c4\ud569\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uc18d \uc2ec\uc0ac \uacbd\ub85c(Fast-Track Regulatory Pathways)\uc758 \ud65c\uc131\ud654: FDA\uc758 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815\uc740 \ud45c\uc900 \uacbd\ub85c \ub300\ube44 \uac1c\ubc1c \uae30\uac04\uc744 \uc57d 3.2\ub144 \ub2e8\ucd95\uc2dc\ud0a4\uba70, &#8216;Project Pragmatica&#8217;\uc640 \uac19\uc740 \uc774\ub2c8\uc154\ud2f0\ube0c\ub294 \uac04\uc18c\ud654\ub41c \uc790\uaca9 \ubc0f \ub370\uc774\ud130 \uc218\uc9d1 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \ucd09\uc9c4\ud569\ub2c8\ub2e4. \uc720\ub7fd \uc758\uc57d\ud488\uccad(EMA)\uc758 PRIME \ud504\ub85c\uadf8\ub7a8 \ub610\ud55c \uc720\uc0ac\ud55c \uac00\uc18d\ud654\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc2a4\ud3f0\uc11c\ub4e4\uc740 1-2\uc0c1 \uc5f0\uad6c\ub97c \ud1b5\ud574 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc218\uc900\uc758 \ub370\uc774\ud130\ub97c \uc0dd\uc131\ud558\ub3c4\ub85d \uc124\uacc4\ud558\uba70, \uc774\ub294 \uacbd\uc7c1\ub825 \uc788\ub294 \ucd9c\uc2dc \uc2dc\uae30\ub97c \uc720\uc9c0\ud558\ub294 \ub370 \ud544\uc218\uc801\uc785\ub2c8\ub2e4.<br \/>\n*   \uc815\ubc00 \uc758\ud559 \ubc0f \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \uce58\ub8cc\ubc95\uc758 \ubaa8\uba58\ud140: 2024\ub144 \uc2b9\uc778\ub41c \ud56d\uc554\uc81c\uc758 70% \uc774\uc0c1\uc774 \ub3d9\ubc18 \uc9c4\ub2e8 \ub610\ub294 \ubc14\uc774\uc624\ub9c8\ucee4 \uacc4\uce35\ud654\ub97c \uc694\uad6c\ud588\uc73c\uba70, \uc774\ub294 \uc815\ubc00 \uc758\ud559\uc774 \uc0c8\ub85c\uc6b4 \ud45c\uc900\uc784\uc744 \ud655\uc778\uc2dc\ucf1c \uc90d\ub2c8\ub2e4. \ucc28\uc138\ub300 \uc5fc\uae30\uc11c\uc5f4 \ubd84\uc11d(NGS) \ubc0f \uc561\uccb4 \uc0dd\uac80\uc758 \ubc1c\uc804\uc740 \uc2e4\uc2dc\uac04 \ubaa8\ub2c8\ud130\ub9c1\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uc548\uc804\uc131 \ud3c9\uac00\ub97c \uac1c\uc120\ud558\uace0 \uce58\ub8cc \uc815\ud655\ub3c4\ub97c \ub192\uc785\ub2c8\ub2e4. AI \ud50c\ub7ab\ud3fc\uc740 \ud658\uc790\ub97c \ud504\ub85c\ud1a0\ucf5c\uacfc \ub9e4\uce6d\ud558\ub294 \ub370 92%\uc758 \uc815\ud655\ub3c4\ub97c \ubcf4\uc5ec\uc8fc\uba70, \uc720\uc804\uccb4 \ub370\uc774\ud130\uc640 AI \uae30\ubc18 \uc2a4\ud06c\ub9ac\ub2dd\uc744 \uacb0\ud569\ud558\ub294 \uc870\uc9c1\uc740 \ub354 \ube60\ub978 \ud658\uc790 \ub4f1\ub85d\uacfc \ub192\uc740 \uc131\uacf5 \ud655\ub960\uc744 \ub2ec\uc131\ud569\ub2c8\ub2e4.<br \/>\n*   \uc2e0\ud765 \uc2dc\uc7a5 \uc784\uc0c1\uc2dc\ud5d8 \uc0ac\uc774\ud2b8 \ud655\uc7a5: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc744 \uc911\uc2ec\uc73c\ub85c \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c \uc784\uc0c1\uc2dc\ud5d8 \uc0ac\uc774\ud2b8\uac00 \ud655\uc7a5\ub418\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc7a5\uae30\uc801\uc778 \uad00\uc810\uc5d0\uc11c \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud569\ub2c8\ub2e4. \ud2b9\ud788 \uc911\uad6d\uc740 \ub300\uaddc\ubaa8 \ubbf8\uce58\ub8cc \ud658\uc790\uad70\uacfc \uc2ec\uc0ac \uae30\uac04 \ub2e8\ucd95\uc73c\ub85c \uc8fc\uc694 \ubaa9\uc801\uc9c0\uac00 \ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e4\uc81c \ub370\uc774\ud130(RWD) \ud1b5\ud569\uc744 \ud1b5\ud55c \ud558\uc774\ube0c\ub9ac\ub4dc \uc99d\uac70 \ud504\ub85c\ud1a0\ucf5c \ud615\uc131: \ubd81\ubbf8\uc640 EU\uac00 \uc8fc\ub3c4\ud558\uba70 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ucc44\ud0dd\ub418\uace0 \uc788\ub294 \ucd94\uc138\ub85c, \uc784\uc0c1\uc2dc\ud5d8\uc758 \ud6a8\uc728\uc131\uc744 \ub192\uc774\uace0 \ub370\uc774\ud130 \uc218\uc9d1 \ubd80\ub2f4\uc744 \uc904\uc785\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<p>*   \uc5c4\uaca9\ud558\uace0 \ubcf5\uc7a1\ud55c \ud658\uc790 \uc120\uc815 \uae30\uc900: \uae30\uc874\uc758 \ud3ec\ud568 \uae30\uc900\uc73c\ub85c\ub294 \ud56d\uc554 \ud658\uc790\uc758 17.0%\ub9cc\uc774 \uc784\uc0c1\uc2dc\ud5d8\uc5d0 \uc801\ud569\ud558\uba70, 56.0%\ub294 \uc9c0\uc5ed \ub0b4 \uc5f0\uad6c \uc635\uc158\uc774 \uc5c6\uc2b5\ub2c8\ub2e4. \uc815\ubc00 \ud504\ub85c\ud1a0\ucf5c\uc740 \ud658\uc790 \ud480\uc744 \ub354\uc6b1 \uc881\ud788\uba70, AI \uae30\ubc18 \uc2a4\ud06c\ub9ac\ub2dd \ub3c4\uad6c\uc758 \ud544\uc694\uc131\uc744 \uc99d\ub300\uc2dc\ud0b5\ub2c8\ub2e4. \uaddc\uc81c \ub2f9\uad6d\uc740 \ub354 \ub113\uc740 \uc790\uaca9 \uae30\uc900\uc744 \uc7a5\ub824\ud558\uc9c0\ub9cc, \ud604\uc7a5 \ucc44\ud0dd\uc740 \uace0\ub974\uc9c0 \uc54a\uc544 \uc2dc\uc791 \uae30\uac04\uc744 \uc5f0\uc7a5\ud558\uace0 \ud658\uc790\ub2f9 \ube44\uc6a9\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \uc784\uc0c1\uc2dc\ud5d8 \ube44\uc6a9 \ubc0f \uc6b4\uc601 \ubd80\ub2f4 \uc99d\uac00: 3\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc758 \ud3c9\uade0 \ube44\uc6a9\uc740 2024\ub144 3,658\ub9cc \ub2ec\ub7ec\ub85c 2018\ub144 \ub300\ube44 30% \uc0c1\uc2b9\ud588\uc73c\uba70, \ud504\ub85c\ud1a0\ucf5c \uc808\ucc28\ub294 2009-2020\ub144 \ub3d9\uc548 67% \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. \ud558\uc774\ube0c\ub9ac\ub4dc \ub370\uc774\ud130 \ucea1\ucc98, \ubd84\uc0b0\ud615 \ubc29\ubb38, \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc(PRO) \ub4f1\uc774 \uc77c\uc0c1\ud654\ub418\uba74\uc11c \ubcf5\uc7a1\uc131\uc774 \uc99d\uac00\ud558\uace0, \uacac\uace0\ud55c \uc778\ud504\ub77c\uc640 \uc804\ubb38 \uc778\ub825\uc774 \uc694\uad6c\ub429\ub2c8\ub2e4.<br \/>\n*   \uc911\ubcf5 \ubc0f \uacbd\uc7c1 \uc5f0\uad6c\ub85c \uc778\ud55c \ud658\uc790 \ud480 \ud3ec\ud654: \uc784\uc0c1\uc2dc\ud5d8 \ubc00\ub3c4\uac00 \ub192\uc740 \ub3c4\uc2dc \ud559\uc220 \ud5c8\ube0c\uc5d0\uc11c \ud2b9\ud788 \uc2ec\uac01\ud558\uba70, \ud658\uc790 \ubaa8\uc9d1\uc5d0 \uc5b4\ub824\uc6c0\uc744 \uacaa\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uad6d\uac00 \uac04 \ub370\uc774\ud130 \ud504\ub77c\uc774\ubc84\uc2dc \ubc95\uaddc\ub85c \uc778\ud55c \ub2e4\uad6d\uc801 \uc784\uc0c1\uc2dc\ud5d8 \ubcf5\uc7a1\uc131: EU\uc758 GDPR, \uc911\uad6d\uc758 CSL \ub4f1 \uc5c4\uaca9\ud55c \uaddc\uc81c\uac00 \ub2e4\uad6d\uc801 \uc784\uc0c1\uc2dc\ud5d8\uc758 \uc6b4\uc601\uc744 \ubcf5\uc7a1\ud558\uac8c \ub9cc\ub4e4\uba70, \uc5f0\ud569 \ub370\uc774\ud130 \uc544\ud0a4\ud14d\ucc98\uc640 \uac19\uc740 \uc194\ub8e8\uc158 \ucc44\ud0dd\uc744 \uc694\uad6c\ud569\ub2c8\ub2e4.<\/p>\n<p>4. \uc138\ubd80 \uc2dc\uc7a5 \ubd84\uc11d<\/p>\n<p>*   \ub2e8\uacc4\ubcc4 (By Phase):<br \/>\n    *   3\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc740 2025\ub144 \uc218\uc775\uc758 38.96%\ub97c \ucc28\uc9c0\ud558\uba70 \uc7ac\uc815\uc801 \uc911\uc694\uc131\uc744 \uc785\uc99d\ud588\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \uc2b9\uc778 \ubc0f \ubcf4\ud5d8 \uae09\uc5ec\uac00 3\uc0c1 \uc131\uacf5\ub960\uc5d0 \uc9c1\uc811\uc801\uc73c\ub85c \uc5f0\uacb0\ub418\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4.<br \/>\n    *   1\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc740 \uc0c8\ub85c\uc6b4 \uce58\ub8cc \uc591\uc2dd\uc774 \ucd08\uae30 \ub2e8\uacc4 \ud30c\uc774\ud504\ub77c\uc778\uc5d0 \uc9c4\uc785\ud558\uba74\uc11c 7.52%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc801\uc751\ud615 \ud50c\ub7ab\ud3fc \ud615\uc2dd\uc740 \uc5ec\ub7ec \ud6c4\ubcf4 \ubb3c\uc9c8\uacfc \uc6a9\ub7c9 \uc694\ubc95\uc744 \ub3d9\uc2dc\uc5d0 \ud14c\uc2a4\ud2b8\ud558\uc5ec \uac1c\ubc1c \uae30\uac04\uc744 \ub2e8\ucd95\ud569\ub2c8\ub2e4.<br \/>\n    *   2\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc740 \ud6a8\ub2a5 \uc99d\uba85\uc774 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815 \ubc0f \ud22c\uc790\uc790 \uc720\uce58\ub97c \uc815\ub2f9\ud654\ud558\ub294 \ubcc0\uace1\uc810 \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4.<br \/>\n    *   4\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc740 \uc2dc\ud310 \ud6c4 \uc2e4\uc81c \uc548\uc804\uc131 \uac10\uc2dc\ub97c \uc704\ud574 \ud544\uc218\uc801\uc774\uba70, \ubd84\uc0b0\ud615 \ucd94\uc801 \uad00\ucc30 \ubc0f \ub514\uc9c0\ud138 \uc99d\uc0c1 \ucd94\uc801\uc744 \ud3ec\ud568\ud558\ub294 \uacbd\uc6b0\uac00 \ub298\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc124\uacc4\ubcc4 (By Design):<br \/>\n    *   \uce58\ub8cc\/\uac1c\uc785 \uc5f0\uad6c\ub294 2025\ub144 \uc804\uccb4 \uc218\uc775\uc758 72.10%\ub97c \ucc28\uc9c0\ud558\uba70 \uc784\uc0c1\uc801 \uc774\uc810 \uac80\uc99d\uc5d0 \ud575\uc2ec\uc801\uc778 \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. \ubb34\uc791\uc704 \ub300\uc870\uad70 \uc5f0\uad6c\ub294 \uc5ec\uc804\ud788 \uac00\uc7a5 \ub192\uc740 \uc99d\uac70 \ud45c\uc900\uc73c\ub85c \uac04\uc8fc\ub429\ub2c8\ub2e4.<br \/>\n    *   \uad00\ucc30 \uc5f0\uad6c\ub294 6.74%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uc2e4\uc81c \ub370\uc774\ud130(RWE)\ub97c \ubcf4\uc644\ud558\ub824\ub294 \uad00\uc2ec\uc774 \ucee4\uc9c0\uace0 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. FDA\uc758 \uc2e4\uc81c \ub370\uc774\ud130 \ud504\ub85c\uadf8\ub7a8\uc740 \ubb34\uc791\uc704\ud654\uc640 \uc2e4\uc6a9\uc801\uc778 \ub370\uc774\ud130 \ucea1\ucc98\ub97c \ud63c\ud569\ud55c \ud558\uc774\ube0c\ub9ac\ub4dc \uc124\uacc4\ub97c \uc7a5\ub824\ud569\ub2c8\ub2e4.<br \/>\n    *   \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8(DCT)\uc740 \ub18d\ucd0c \ubc0f \uc774\ub3d9\uc774 \uc5b4\ub824\uc6b4 \ud658\uc790\uc5d0\uac8c \uc811\uadfc\uc131\uc744 \ud655\ub300\ud558\uc5ec \ubaa8\uc9d1 \ud480\uc744 \ud48d\ubd80\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uc554 \uc720\ud615\ubcc4 (By Cancer Type):<br \/>\n    *   \uc720\ubc29\uc554\uc740 2025\ub144 \ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5 \uc218\uc775\uc758 15.18%\ub97c \ucc28\uc9c0\ud558\uba70 \uc9c0\uc18d\uc801\uc778 \uc911\uc694\uc131\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ub2e4\uc591\ud55c \ubc14\uc774\uc624\ub9c8\ucee4 \ud558\uc704 \uc720\ud615(HER2 \uc591\uc131, \uc0bc\uc911 \uc74c\uc131, ER \uc591\uc131)\uc740 \ubcf5\ud569 \uc694\ubc95 \ubc0f \uc720\uc9c0 \uc804\ub7b5\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \uc218\uc694\ub97c \ucc3d\ucd9c\ud569\ub2c8\ub2e4.<br \/>\n    *   \uc804\ub9bd\uc120\uc554\uc740 PARP \uc5b5\uc81c\uc81c, PSMA \ud45c\uc801 \ubc29\uc0ac\uc131 \ub9ac\uac04\ub4dc, \ucca8\ub2e8 \uc601\uc0c1 \uc720\ub3c4 \uac1c\uc785 \ub4f1\uc758 \uc601\ud5a5\uc73c\ub85c 2031\ub144\uae4c\uc9c0 7.90%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70 \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \ud3d0\uc554\uc740 EGFR \ubcc0\uc774 \ube44\uc18c\uc138\ud3ec\uc554\uc744 \ud3c9\uac00\ud558\ub294 \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4 \ubc0f \uc774\uc911 \ud2b9\uc774\uc131 \ud56d\uccb4 \uc5f0\uad6c\ub97c \uc911\uc2ec\uc73c\ub85c \ud65c\ubc1c\ud569\ub2c8\ub2e4.<br \/>\n    *   \uc885\uc591 \ubd88\uac00\uc9c0\ub860\uc801(Tumor-agnostic) \uc2b9\uc778\uc740 \ud574\ubd80\ud559\uc801 \uae30\uc6d0\ubcf4\ub2e4\ub294 \ubd84\uc790 \ub3d9\uc778\uc5d0 \uc758\ud574 \uc815\uc758\ub418\ub294 \uc801\uc751\uc99d\uc5d0\uc11c \ubc14\uc2a4\ucf13 \uc784\uc0c1\uc2dc\ud5d8\uc744 \uac00\uc18d\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc591\uc2dd\ubcc4 (By Therapeutic Modality):<br \/>\n    *   \uba74\uc5ed\uce58\ub8cc\ub294 2025\ub144 \uc218\uc775\uc758 33.65%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\ub7ec \uc885\uc591 \uc720\ud615\uc5d0\uc11c \uba74\uc5ed\uad00\ubb38 \uc5b5\uc81c\uc81c \uc720\uc9c0 \uc694\ubc95\uc744 \uc911\uc2ec\uc73c\ub85c \uc120\ub450\ub97c \ub2ec\ub838\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\ub294 7.63%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ubd84\uc57c\uc785\ub2c8\ub2e4. CAR-T \ud50c\ub7ab\ud3fc\uc740 \uace0\ud615\uc554 \ud14c\uc2a4\ud2b8 \ub2e8\uacc4\uc5d0 \uc9c4\uc785\ud558\uc5ec \ub300\uc0c1 \ud658\uc790\uad70\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC)\ub294 \ub9c1\ucee4-\ud398\uc774\ub85c\ub4dc \uae30\uc220 \ubc1c\uc804\uc758 \ud61c\ud0dd\uc744 \ubc1b\uc544 \ub354 \ub192\uc740 \ud6a8\ub2a5\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n    *   \uc790\uac00 \uc138\ud3ec \uce58\ub8cc\uc81c\uc758 \ubcf5\uc7a1\ud55c \uc81c\uc870 \uacfc\uc815\uc740 \uadf9\uc800\uc628 \ubb3c\ub958 \uc5ed\ub7c9\uacfc \uaddc\uc81c \uce5c\uc219\ub3c4\uac00 \uc788\ub294 \uc9c0\uc5ed\uc73c\ub85c \uc0ac\uc774\ud2b8 \uc120\uc815\uc744 \uc720\ub3c4\ud569\ub2c8\ub2e4.<\/p>\n<p>5. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uc804 \uc138\uacc4 \uc218\uc775\uc758 46.12%\ub97c \ucc28\uc9c0\ud558\uba70 FDA\uc758 \uc720\uc5f0\ud55c \uc2e0\uc18d \uc2ec\uc0ac \uba54\ucee4\ub2c8\uc998\uacfc \uacac\uace0\ud55c \uc9c0\ubd88\uc790 \uc778\ud504\ub77c\uc5d0 \ud798\uc785\uc5b4 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \ud559\uc220 \uc13c\ud130\ub294 \ubd84\uc790 \uc885\uc591\ud559\uc5d0 \ub300\ud55c \uae4a\uc740 \uc804\ubb38 \uc9c0\uc2dd\uc744 \uc81c\uacf5\ud558\uc5ec \ubcf5\uc7a1\ud55c \uc801\uc751\ud615 \ud504\ub85c\ud1a0\ucf5c\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 6.31%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uc911\uad6d\uc740 2024\ub144 \uc804 \uc138\uacc4 \uc2e0\uaddc \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc791\uc758 26.5%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc2ec\uc0ac \uae30\uac04 \ub2e8\ucd95\uc73c\ub85c \ub300\uaddc\ubaa8 \ubbf8\uce58\ub8cc \ud658\uc790 \ubaa8\uc9d1\uc758 \uc8fc\uc694 \ubaa9\uc801\uc9c0\uac00 \ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc778\ub3c4\uc758 \uac04\uc18c\ud654\ub41c 2019\ub144 \uaddc\uc81c \ub610\ud55c \ud6a8\uc728\uc131\uc744 \uc81c\uacf5\ud558\uba70, \ud558\uc774\ub370\ub77c\ubc14\ub4dc\uc640 \ubcb5\uac08\ub8e8\ub8e8\uc758 \ud56d\uc554 \uc804\ubb38 \ud074\ub7ec\uc2a4\ud130\ub294 1\uc0c1 \uc778\ud504\ub77c\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: EMA\uc758 \uc870\ud654\ub85c\uc6b4 \uaddc\uc81c\uc640 \ud559\uacc4-\uc0b0\uc5c5 \uac04\uc758 \uac15\ub825\ud55c \uc2dc\ub108\uc9c0\ub97c \ud1b5\ud574 \ud65c\ubc1c\ud55c \ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. GDPR\uc740 \uc815\uad50\ud55c \ub370\uc774\ud130 \ud504\ub77c\uc774\ubc84\uc2dc \uc900\uc218\ub97c \uc694\uad6c\ud558\uba70, \uc2a4\ud3f0\uc11c\ub4e4\uc740 \uc6d0\ucc9c\uc5d0\uc11c \uac1c\uc778 \uac74\uac15 \uc815\ubcf4\ub97c \uc775\uba85\ud654\ud558\ub294 \uc5f0\ud569 \ub370\uc774\ud130 \uc544\ud0a4\ud14d\ucc98\ub97c \ucc44\ud0dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub3d9\uc720\ub7fd, \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74, \uc911\ub3d9\uc740 \uc2e0\ud765 2\ucc28 \ud5c8\ube0c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \ud1b5\ud569\uc744 \ubcf4\uc774\uba70, \uc0c1\uc704 9\uac1c CRO\uac00 \uc804 \uc138\uacc4 \uc218\uc775\uc758 \uc57d 60%\ub97c \ud1b5\uc81c\ud569\ub2c8\ub2e4. \uc774\ub294 \ub300\ud615 \ubc14\uc774\uc624 \uc81c\uc57d\uc0ac\uc5d0\uac8c \ub2e4\uc591\ud55c \ud30c\ud2b8\ub108 \uc120\ud0dd\uad8c\uc744 \uc81c\uacf5\ud558\ub294 \ub3d9\uc2dc\uc5d0 \uc911\uacac \uc5c5\uccb4\ub4e4\uc5d0\uac8c\ub294 \uc804\ubb38\ud654 \ub610\ub294 \ud569\ubcd1\uc744 \ud1b5\ud55c \ucc28\ubcc4\ud654\ub97c \uc694\uad6c\ud569\ub2c8\ub2e4. IQVIA, Parexel, ICON, Syneos Health\uc640 \uac19\uc740 \uc8fc\uc694 CRO\ub4e4\uc740 \uc778\uacf5\uc9c0\ub2a5(AI) \ud22c\uc790\ub97c \ud1b5\ud574 \uc5f0\uad6c \uc2dc\uc791 \ubc0f \ud658\uc790 \ub4f1\ub85d \uc608\uce21\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Worldwide Clinical Trials\uc640 \uac19\uc740 \uc18c\uaddc\ubaa8 \uc804\ubb38 \uc5c5\uccb4\ub4e4\uc740 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc81c\uc870 \ub178\ud558\uc6b0\uc5d0 \uc9d1\uc911\ud558\uc5ec \ub9c8\uc9c4\uc744 \ubc29\uc5b4\ud569\ub2c8\ub2e4.<\/p>\n<p>\uae30\uc220 \ucc44\ud0dd\uc740 \uc774\uc81c \uc8fc\uc694 \uacbd\uc7c1 \ucc28\ubcc4\ud654 \uc694\uc18c\uc785\ub2c8\ub2e4. AI \uae30\ubc18 \ud658\uc790 \ub9e4\uce6d \uc2dc\uc2a4\ud15c\uc740 \ud6c4\ubcf4\uc790 \ud504\ub85c\ud544\uacfc \ud504\ub85c\ud1a0\ucf5c \uaddc\uce59\uc744 92%\uc758 \uc815\ud655\ub3c4\ub85c \uc77c\uce58\uc2dc\ucf1c \uc2a4\ud06c\ub9ac\ub2dd \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\uace0 \ubaa8\uc9d1 \uc704\ud5d8\uc744 \uc904\uc785\ub2c8\ub2e4. CRO\ub4e4\uc740 Medable\uacfc \uac19\uc740 \ub514\uc9c0\ud138 \ud5ec\uc2a4 \uae30\uc5c5\uacfc \ud611\ub825\ud558\uc5ec ePRO, \uc6d0\uaca9 \ubc29\ubb38, \uc7ac\ud0dd \uac04\ud638 \ubaa8\ub4c8\uc744 \ud1b5\ud569\ud55c \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \ud234\ud0b7\uc744 \uad6c\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. M&#038;A \ub610\ud55c \ud65c\ubc1c\ud558\uba70, palleos healthcare\uc640 OCT Clinical\uc758 \ud569\ubcd1\uc740 \uc720\ub7fd \uc2dc\uc7a5 \uc811\uadfc\uc131\uacfc \uce58\ub8cc \uc601\uc5ed \ud655\ub300\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>7. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 6\uc6d4: Charles River Laboratories\ub294 \uccb4\uc678 \ud56d\uc554 \uc11c\ube44\uc2a4\ub97c \ud655\uc7a5\ud558\uace0, \ubc1c\uacac \uc6cc\ud06c\ud50c\ub85c\uc6b0\ub97c \uac04\uc18c\ud654\ud558\ub294 \ud074\ub77c\uc6b0\ub4dc \ud50c\ub7ab\ud3fc &#8216;Apollo for CRADL&#8217;\uc744 \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 6\uc6d4: START\uc640 OneOncology\ub294 \ubbf8\uad6d \uc804\uc5ed\uc5d0 \ucd08\uae30 \ub2e8\uacc4 \uc784\uc0c1\uc2dc\ud5d8 \uc0ac\uc774\ud2b8\ub97c \uad6c\ucd95\ud558\uae30 \uc704\ud574 \ud611\ub825\ud558\uc5ec \ud658\uc790\ub4e4\uc774 \uc2e4\ud5d8\uc801 \uce58\ub8cc\ubc95\uc5d0 \ub354 \uc27d\uac8c \uc811\uadfc\ud560 \uc218 \uc788\ub3c4\ub85d \ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 5\uc6d4: Medable\uc740 \ub514\uc9c0\ud138 \ucc38\uc5ec\ub97c \ud1b5\ud574 \ubb3c\ub958\uc801 \uc5b4\ub824\uc6c0\uc744 \uc904\uc774\ub294 \ud1b5\ud569 \ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \ud50c\ub7ab\ud3fc\uc744 \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 3\uc6d4: AstraZeneca\ub294 \ubc29\uc0ac\uc131 \uc811\ud569\uccb4 \ud30c\uc774\ud504\ub77c\uc778\uc744 \uac15\ud654\ud558\uae30 \uc704\ud574 Fusion Pharmaceuticals\ub97c 20\uc5b5 \ub2ec\ub7ec\uc5d0 \uc778\uc218\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 2\uc6d4: Merck\ub294 LaNova Medicines\ub85c\ubd80\ud130 \ud56dPD-1\/VEGF \uc774\uc911 \ud2b9\uc774\uc131 \ud56d\uccb4\uc778 LM-299\uc5d0 \ub300\ud55c \ub3c5\uc810\uc801\uc778 \uae00\ub85c\ubc8c \ub77c\uc774\uc120\uc2a4\ub97c \ud68d\ub4dd\ud558\uc5ec \uba74\uc5ed\uce58\ub8cc \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \ub2e4\uac01\ud654\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacb0\ub860\uc801\uc73c\ub85c, \ud56d\uc554 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 \uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00\uc640 \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\ubc95 \uac1c\ubc1c \ub178\ub825\uc5d0 \ud798\uc785\uc5b4 \uacac\uace0\ud55c \uc131\uc7a5\uc744 \uc9c0\uc18d\ud560 \uac83\uc785\ub2c8\ub2e4. \uae30\uc220 \ubc1c\uc804\uacfc \uaddc\uc81c \ud658\uacbd\uc758 \ubcc0\ud654\ub294 \uc2dc\uc7a5\uc758 \ud6a8\uc728\uc131\uc744 \ub192\uc774\uace0 \uc0c8\ub85c\uc6b4 \uae30\ud68c\ub97c \ucc3d\ucd9c\ud558\uace0 \uc788\uc73c\ub098, \ub192\uc740 \ube44\uc6a9\uacfc \ubcf5\uc7a1\ud55c \ud658\uc790 \ubaa8\uc9d1\uc740 \uc5ec\uc804\ud788 \ud574\uacb0\ud574\uc57c \ud560 \uacfc\uc81c\ub85c \ub0a8\uc544 \uc788\uc2b5\ub2c8\ub2e4. CRO\ub4e4\uc740 \uc804\ubb38\ud654\uc640 \uae30\uc220 \ub3c4\uc785\uc744 \ud1b5\ud574 \uacbd\uc7c1\ub825\uc744 \ud655\ubcf4\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \uc5ed\ub3d9\uc801\uc778 \uc131\uc7a5 \ub3d9\ub825\uc744 \uc81c\uacf5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \ud56d\uc554\uc81c \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ubcf8 \uc2dc\uc7a5\uc740 \uc784\uc0c1 1\uc0c1\ubd80\ud130 4\uc0c1\uae4c\uc9c0\uc758 \ud56d\uc554\uc81c \uc5f0\uad6c\uc5d0 \ud22c\uc785\ub418\ub294 \uc2a4\ud3f0\uc11c \uc9c0\ucd9c\uc744 \ucd1d\uad04\ud558\uba70, \uc2dc\ud5d8\uae30\uad00 \ubc0f CRO \uc218\uc218\ub8cc, \ud658\uc790 \uad00\ub828 \ube44\uc6a9, \ubc14\uc774\uc624\ub9c8\ucee4 \ubc0f \uc601\uc0c1 \ud3c9\uac00, \uaddc\uc81c \uc81c\ucd9c \ube44\uc6a9 \ub4f1\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \uc21c\uc218 \uc778\uc2e4\ub9ac\ucf54 \uc2dc\ubbac\ub808\uc774\uc158 \uc5f0\uad6c \ubc0f \uc7a5\uae30 \uc2dc\ud310 \ud6c4 \ub4f1\ub85d \uc5f0\uad6c\ub294 \ubd84\uc11d \ubc94\uc704\uc5d0\uc11c \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>2026\ub144 \uae30\uc900 146.3\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc778 \uc774 \uc2dc\uc7a5\uc740 2031\ub144\uc5d0\ub294 187.9\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uc804 \uc138\uacc4\uc801\uc778 \uc554 \ubc1c\ubcd1\ub960 \ubc0f \uc720\ubcd1\ub960 \uc99d\uac00, \uc81c\uc57d \ubc0f \ubc14\uc774\uc624\ud14d\uc758 \ud56d\uc554 R&#038;D \ud22c\uc790 \ud655\ub300, \uc2e0\uc18d \uc2ec\uc0ac \uc81c\ub3c4(Breakthrough, Prime \ub4f1) \ub3c4\uc785, \uc815\ubc00 \uc758\ud559 \ubc0f \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \uce58\ub8cc\ubc95\uc758 \ubc1c\uc804, \uc2e0\ud765 \uc2dc\uc7a5 \ub0b4 \uc784\uc0c1\uc2dc\ud5d8 \uc0ac\uc774\ud2b8 \ud655\uc7a5, \uadf8\ub9ac\uace0 \uc2e4\uc81c \uc784\uc0c1 \ub370\uc774\ud130(RWD) \ud1b5\ud569\uc744 \ud1b5\ud55c \ud558\uc774\ube0c\ub9ac\ub4dc \uc99d\uac70 \ud504\ub85c\ud1a0\ucf5c \uad6c\ucd95 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc5c4\uaca9\ud558\uace0 \ubcf5\uc7a1\ud55c \ud658\uc790 \uc120\uc815 \uae30\uc900\uc740 \ud658\uc790 \ubaa8\uc9d1\uc744 \uc9c0\uc5f0\uc2dc\ud0a4\uace0, \uc784\uc0c1\uc2dc\ud5d8 \ube44\uc6a9 \ubc0f \uc6b4\uc601 \ubd80\ub2f4 \uc99d\uac00, \uacbd\uc7c1 \uc5f0\uad6c\uc758 \uc911\ubcf5\uc73c\ub85c \uc778\ud55c \ud658\uc790 \ud480 \ud3ec\ud654, \uadf8\ub9ac\uace0 \uad6d\uacbd \uac04 \ub370\uc774\ud130 \ud504\ub77c\uc774\ubc84\uc2dc \ubc95\uaddc\uc758 \ubcf5\uc7a1\uc131\uc740 \ub2e4\uad6d\uac00 \uc784\uc0c1\uc2dc\ud5d8\uc5d0 \uc81c\uc57d\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654\ub294 \uc784\uc0c1 \ub2e8\uacc4(1\uc0c1~4\uc0c1), \uc5f0\uad6c \uc124\uacc4(\uce58\ub8cc\/\uc911\uc7ac \uc5f0\uad6c, \uad00\ucc30 \uc5f0\uad6c), \uc554 \uc720\ud615(\ud3d0\uc554, \uc720\ubc29\uc554, \ub300\uc7a5\uc554, \ubc31\ud608\ubcd1, \uc804\ub9bd\uc120\uc554 \ub4f1), \uce58\ub8cc \uc591\uc2dd(\uba74\uc5ed\uce58\ub8cc, \ud45c\uc801\uce58\ub8cc, \ud654\ud559\uc694\ubc95, \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \ub4f1), \uadf8\ub9ac\uace0 \uc9c0\uc5ed\ubcc4\ub85c \uc774\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4. \ud2b9\ud788 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc911\uad6d\uacfc \uc778\ub3c4\uc758 \uaddc\uc81c \uac00\uc18d\ud654 \ubc0f \uce58\ub8cc \uacbd\ud5d8\uc774 \uc5c6\ub294 \ud658\uc790\uad70 \uc811\uadfc\uc131 \ub355\ubd84\uc5d0 6.31%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc744 \ubcf4\uc774\uba70 \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud569\ub2c8\ub2e4. \uc784\uc0c1 \ub2e8\uacc4\ubcc4\ub85c\ub294 \ucd08\uae30 \ub2e8\uacc4 \ud601\uc2e0\uacfc \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \ud30c\uc774\ud504\ub77c\uc778 \uc131\uc7a5\uc5d0 \ud798\uc785\uc5b4 1\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc774 7.52%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uce58\ub8cc \uc591\uc2dd \uc911\uc5d0\uc11c\ub294 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uac00 CAR-T \ubc0f \uc720\uc804\uc790 \ud3b8\uc9d1 \ud50c\ub7ab\ud3fc\uc758 \ubc1c\uc804\uc73c\ub85c \uace0\ud615\uc554 \uc801\uc6a9\uc774 \ud655\ub300\ub418\uba74\uc11c 7.63%\ub85c \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uaddc\uc81c \ub2f9\uad6d\uc774 \uc2e4\uc81c \uc784\uc0c1 \ub370\uc774\ud130\ub97c \uc810\ucc28 \uc218\uc6a9\ud568\uc5d0 \ub530\ub77c \uad00\ucc30 \uc5f0\uad6c \ubc0f \ud558\uc774\ube0c\ub9ac\ub4dc \uc124\uacc4\ub294 6.74%\uc758 CAGR\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc6b4\uc601\uc0c1\uc758 \uc8fc\uc694 \uacfc\uc81c\ub85c\ub294 3\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc758 \ud3c9\uade0 3,658\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \ube44\uc6a9 \uc0c1\uc2b9\uacfc \ud658\uc790 \uc811\uadfc\uc131\uc744 \uc81c\ud55c\ud558\ub294 \uc5c4\uaca9\ud55c \uc790\uaca9 \uae30\uc900\uc774 \uc9c0\uc801\ub429\ub2c8\ub2e4. \uacbd\uc7c1 \ud658\uacbd\uc740 IQVIA, Parexel, ICON \ub4f1 \uc8fc\uc694 CRO \uae30\uc5c5\ub4e4\uacfc AstraZeneca, Johnson &#038; Johnson, F. Hoffmann-La Roche, Pfizer, Novartis \ub4f1 \uc120\ub3c4\uc801\uc778 \uc81c\uc57d\uc0ac\ub4e4\uc774 \uacbd\uc7c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\uc758 \uc5f0\uad6c \ubc29\ubc95\ub860\uc740 \uc9c0\ucd9c \uad6c\uc131 \uc694\uc18c\uc758 \uc5c4\uaca9\ud55c \uc120\uc815, \uc2e4\uc2dc\uac04 \uc784\uc0c1 \ub2e8\uacc4\ubcc4 \ucd94\uc801, \uc5f0\uac04 \ub370\uc774\ud130 \uc5c5\ub370\uc774\ud2b8\ub97c \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uc2e0\ub8b0\uc131 \uc788\ub294 \ubd84\uc11d\uc744 \uc704\ud55c \uade0\ud615 \uc7a1\ud788\uace0 \ud22c\uba85\ud55c \uae30\uc900\uc120\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-35593","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/35593"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=35593"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/35593\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=35593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=35593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=35593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}